Disseminated intravascular coagulation, usually called DIC, is a serious clotting disorder in which the body forms widespread clots and may also run out of the platelets and clotting proteins needed to stop bleeding. Fibrinogen and fibrin degradation products, or FDP, help show both sides of that process. Fibrinogen is a clot-building protein. FDP are fragments released when fibrin and fibrinogen are broken down. When DIC is suspected, doctors do not interpret these two tests alone. They compare them with platelet count, PT/INR, aPTT, D-dimer, bleeding signs, organ function, and the illness that triggered the problem. The most concerning pattern is falling fibrinogen with rising FDP, especially when platelets are dropping and PT is prolonged. A normal fibrinogen result does not always rule out DIC, because fibrinogen can rise during inflammation.
- Fibrinogen usually measures about 200–400 mg/dL, but each lab sets its own reference range.
- FDP is usually low or negative; many labs use less than 5 mcg/mL as a typical negative range.
- High FDP means active clot or fibrinogen breakdown, but it does not prove DIC by itself.
- Low fibrinogen with high FDP, low platelets, and prolonged PT strongly supports advanced or bleeding-type DIC.
- Normal or high fibrinogen can occur in early sepsis-related DIC because fibrinogen rises with inflammation.
- New bleeding, confusion, shortness of breath, low blood pressure, or reduced urination with abnormal clotting tests needs urgent medical care.
Table of Contents
- What Fibrinogen and FDP Show During DIC
- Normal Ranges and Results That Need Urgent Attention
- DIC Patterns With Fibrinogen and FDP
- Why DIC Results Can Change Over Hours
- How Doctors Use the Full Clotting Panel
- Common Causes and Lookalikes
- What Follow-Up Usually Involves
- Patient Safety and Next Steps
What Fibrinogen and FDP Show During DIC
Fibrinogen is the raw material the body uses to build a stable clot. When bleeding starts, thrombin converts fibrinogen into fibrin strands. Those strands help form a mesh that holds platelets and red blood cells together at the injury site. In DIC, that clotting process spreads through the bloodstream instead of staying limited to one damaged vessel.
FDP, short for fibrin or fibrinogen degradation products, are fragments produced when the body breaks down fibrin or fibrinogen. They rise when the clotting-and-breakdown system is highly active. FDP can come from breakdown of cross-linked fibrin clots, from breakdown of soluble fibrin, or from direct breakdown of fibrinogen. That is why FDP can be high in DIC, major trauma, recent surgery, severe infection, cancer, pregnancy complications, and large clots.
DIC creates a confusing pattern because clotting and bleeding can happen at the same time. Tiny clots can block blood flow in organs such as the kidneys, lungs, liver, or brain. At the same time, the body may consume platelets, fibrinogen, and other clotting factors so quickly that bleeding becomes harder to control. A person may have oozing from IV lines, bruising, nosebleeds, gastrointestinal bleeding, or heavy surgical-site bleeding while also having organ injury from microclots.
Fibrinogen and FDP are helpful because they point to different parts of the process:
- Fibrinogen shows how much clot-building protein remains available.
- FDP shows how much clot or fibrinogen breakdown is occurring.
- A falling fibrinogen level suggests consumption, dilution, liver synthetic failure, or major blood loss.
- A rising FDP level suggests active breakdown of fibrin or fibrinogen.
- The combination of falling fibrinogen and rising FDP suggests an intense cycle of clot formation and clot breakdown.
DIC is still not diagnosed from one number. A high FDP result alone is too broad. A low fibrinogen result alone can occur for reasons other than DIC. The pattern becomes more meaningful when it appears alongside falling platelets, a prolonged PT, a prolonged aPTT, a very high D-dimer, and a known trigger such as sepsis, trauma, obstetric hemorrhage, acute promyelocytic leukemia, severe liver disease, or a severe transfusion reaction.
Many hospitals also measure D-dimer. D-dimer is a specific breakdown product of cross-linked fibrin, so it points more directly to clot formation followed by clot breakdown. FDP is broader because it can reflect breakdown of fibrin and fibrinogen. In practice, some hospitals use D-dimer more often than FDP, while others report both. When both are available, a very high FDP with a high D-dimer supports active fibrinolysis, but the exact meaning depends on the clinical setting.
For readers comparing results, the article on D-dimer with fibrinogen can help separate clot formation from clot breakdown, while the FDP test is the more focused marker for fibrin and fibrinogen degradation.
Normal Ranges and Results That Need Urgent Attention
Fibrinogen is commonly reported in mg/dL in the United States and g/L in many other countries. A typical adult reference range is about 200–400 mg/dL, which equals 2.0–4.0 g/L. Some labs use ranges such as 180–350 mg/dL or 200–450 mg/dL. Pregnancy, inflammation, infection, smoking, age, estrogen therapy, and some cancers can raise fibrinogen.
FDP reference ranges vary more because labs use different methods. Many laboratories report FDP as negative, positive, or in categories. Others give a number, often in mcg/mL. A common negative range is less than 5 mcg/mL, but the report’s own reference interval should be used. Some FDP assays report higher cutoffs or semi-quantitative bands such as 5–20, 20–40, or greater than 40 mcg/mL.
Fibrinogen below 150 mg/dL is concerning in a bleeding patient. Fibrinogen below 100 mg/dL, or 1.0 g/L, is often treated as severe hypofibrinogenemia in DIC scoring and bleeding management. In major bleeding, obstetric hemorrhage, trauma, or surgery, clinicians may aim for higher fibrinogen targets than the bare minimum because clot strength can fail before fibrinogen reaches extremely low levels.
FDP elevation needs context. A mild increase after surgery or trauma may reflect expected clot repair. A large increase in a critically ill patient with low platelets and prolonged clotting times is more concerning. A high FDP result becomes more urgent when the patient also has:
- Unexplained bleeding from gums, nose, urine, stool, wounds, IV sites, or surgical drains
- New purple skin changes, mottled skin, blackened fingertips or toes, or widespread bruising
- Falling blood pressure, fast heart rate, fainting, or shock
- Shortness of breath, chest pain, confusion, seizure, or new weakness
- Reduced urine output or rapidly worsening kidney tests
- A platelet count falling quickly over hours or days
- PT/INR or aPTT becoming longer on repeat testing
Pregnancy needs special caution. Fibrinogen normally rises during pregnancy, often reaching levels above nonpregnant adult ranges. A fibrinogen value that looks “normal” for a nonpregnant adult may be abnormal for late pregnancy if there is placental abruption, amniotic fluid embolism, postpartum hemorrhage, severe preeclampsia, or HELLP syndrome. In obstetric emergencies, a rapid fall from a high pregnancy baseline can be more informative than a single number.
A single normal result should not create false reassurance when the clinical picture is worsening. DIC can evolve quickly, and fibrinogen may lag behind other markers early in sepsis. Inflammation can push fibrinogen upward at the same time clotting consumes it. A value of 300 mg/dL may be normal on paper, but if it fell from 600 mg/dL in a patient with sepsis and rising FDP, the direction of change may be important.
The fibrinogen reference range gives more detail on units and routine interpretation. For DIC, though, the trend often carries more weight than whether one value sits inside the printed normal interval.
DIC Patterns With Fibrinogen and FDP
Fibrinogen and FDP patterns are easiest to interpret when grouped by clinical pattern rather than by isolated high-or-low labels. DIC is a dynamic syndrome, so one person’s results may move from one pattern to another as the illness changes.
| Pattern | Common meaning | Why it matters |
|---|---|---|
| Low fibrinogen, high FDP | Strong concern for advanced DIC, severe bleeding-type DIC, massive fibrinolysis, or major consumption | Bleeding risk can be high, especially with low platelets and prolonged PT |
| Normal or high fibrinogen, high FDP | Possible early DIC, sepsis-related DIC, inflammation, cancer, recent surgery, trauma, or clot breakdown | Fibrinogen may be preserved because it rises as an acute-phase protein |
| Low fibrinogen, normal or mildly high FDP | Possible liver synthetic failure, inherited fibrinogen disorder, dilution from fluids or transfusion, or severe blood loss | Not the classic DIC pattern unless other tests and clinical signs support it |
| High fibrinogen, normal FDP | Inflammation, infection, pregnancy, smoking, obesity, or chronic disease without major active fibrinolysis | Does not suggest DIC by itself |
| Falling fibrinogen, rising FDP | Worsening consumption and breakdown over time | The trend can be more concerning than either value alone |
Low fibrinogen with high FDP
Low fibrinogen with high FDP is the classic high-risk pattern people often associate with DIC. It means the body may be using up fibrinogen while also breaking down fibrin or fibrinogen at a high rate. This pattern is especially concerning when platelets are low, PT is prolonged, and the patient is bleeding.
This pattern can occur in severe trauma, obstetric catastrophe, acute promyelocytic leukemia, advanced sepsis, severe shock, and massive transfusion. It can also appear when fibrinolysis is very active, meaning the body is breaking down clots aggressively. In these cases, bleeding may be prominent because the clot-building system cannot keep up.
Normal or high fibrinogen with high FDP
Normal or high fibrinogen with high FDP can still fit DIC, especially in sepsis or early inflammatory DIC. Fibrinogen is an acute-phase protein, so the liver may make more of it during inflammation. The measured level may stay normal or high even while fibrinogen is being consumed. This is one reason DIC scoring systems do not rely heavily on fibrinogen alone.
This pattern may also occur after surgery, trauma, deep vein thrombosis, pulmonary embolism, cancer, inflammatory disease, or pregnancy. It needs correlation with symptoms and other labs. If platelets are stable and PT/aPTT are normal, doctors may look for non-DIC causes of FDP elevation. If platelets are falling and clotting times are lengthening, DIC stays on the table.
Low fibrinogen with only mild FDP elevation
Low fibrinogen with only mild FDP elevation is not the typical DIC pattern, although it can appear in complex cases. Doctors often consider other explanations, such as severe liver disease, inherited fibrinogen deficiency, acquired dysfibrinogenemia, dilution after large volumes of IV fluids, massive transfusion, or loss of clotting proteins during major bleeding.
This pattern matters because the treatment may differ. For example, liver disease can prolong PT/INR and lower fibrinogen without the same widespread clotting-and-breakdown cycle seen in DIC. A clinician may check liver tests, factor levels, thrombin time, reptilase time, and the patient’s bleeding history.
Falling fibrinogen with rising FDP
A worsening trend is often more important than one snapshot. If fibrinogen falls from 450 to 220 to 120 mg/dL while FDP rises and platelets fall, the pattern suggests accelerating consumption and breakdown even before the fibrinogen becomes extremely low. Repeating tests every several hours may be necessary in unstable hospitalized patients.
Trend interpretation also helps avoid overcalling DIC in stable outpatients. A mildly high FDP with stable fibrinogen, normal platelets, normal PT, and no severe illness is not the same as a rapidly changing pattern in a patient with septic shock.
Why DIC Results Can Change Over Hours
DIC is not a fixed lab diagnosis. It is a process that can speed up, slow down, or shift direction as the underlying illness changes. The body may begin with excess clotting, then move into a stage where clotting proteins and platelets are depleted. Some patients mainly show organ injury from microclots. Others mainly show bleeding. Many show both.
Fibrinogen can be misleading early because the liver produces it during inflammation. In sepsis, pneumonia, pancreatitis, burns, inflammatory cancers, and severe tissue injury, fibrinogen can rise sharply. A patient may have active coagulation and fibrin breakdown but still show a fibrinogen result in the normal range. This does not mean the coagulation system is normal. It means production and consumption may be happening at the same time.
FDP can also change quickly. When clot breakdown increases, FDP may rise before fibrinogen becomes low. If fibrinolysis is suppressed, as can happen in some sepsis-related patterns, FDP and D-dimer may be less dramatic than expected despite serious microvascular clotting. This is one reason doctors also watch platelet trend, PT/INR, organ function, lactate, blood pressure, and clinical signs.
Different DIC triggers often create different patterns:
- Sepsis commonly causes inflammation-driven coagulation activation and may show normal or high fibrinogen early.
- Trauma and obstetric hemorrhage can cause rapid fibrinogen loss and high FDP from bleeding, tissue injury, and fibrinolysis.
- Acute promyelocytic leukemia can cause strong fibrinolytic activity and serious bleeding risk.
- Solid tumors may cause slower, chronic DIC with elevated FDP or D-dimer and less dramatic fibrinogen changes.
- Aortic aneurysm or large vascular malformations can cause chronic clot formation and breakdown.
DIC can also improve quickly when the trigger is controlled. For example, treating sepsis, delivering the placenta in a severe obstetric complication, treating acute promyelocytic leukemia, controlling bleeding, or removing infected tissue can slow the abnormal clotting cycle. Lab recovery may lag behind clinical improvement, but stabilizing platelets, shortening PT, falling FDP, and rising fibrinogen are reassuring trends.
Because DIC moves over time, clinicians usually repeat tests rather than relying on one panel. The timing depends on severity. A stable patient may need repeat testing the next day. A critically ill or actively bleeding patient may need repeat testing every few hours.
How Doctors Use the Full Clotting Panel
Doctors interpret fibrinogen and FDP as part of a broader clotting picture. A typical DIC evaluation may include platelet count, PT/INR, aPTT, fibrinogen, D-dimer or FDP, complete blood count, blood smear, liver tests, kidney tests, lactate, and markers of the underlying illness. The coagulation panel is often paired with a CBC because DIC commonly affects both clotting proteins and platelets.
The platelet count is important because platelets are consumed during widespread clotting. A falling platelet count can be more meaningful than a single mildly low result. A person whose platelets fall from 240 to 90 x 10^9/L over a short time may be more concerning than a person with a stable chronic platelet count of 90 x 10^9/L. A very low platelet count also increases bleeding risk, especially when fibrinogen is low.
PT and INR reflect the extrinsic and common clotting pathways. PT often becomes prolonged in DIC because clotting factors are consumed. aPTT may also become prolonged, especially in more advanced cases. A prolonged PT result with low fibrinogen and high FDP is more concerning than an abnormal FDP result alone.
The ISTH overt DIC scoring approach has traditionally used platelet count, fibrin-related markers, PT prolongation, and fibrinogen. A score of 5 or more has been considered compatible with overt DIC when there is an underlying condition known to trigger DIC. More recent ISTH work emphasizes that DIC can appear in earlier phases and with different thrombotic or hemorrhagic phenotypes. That newer framework helps explain why a person can have serious DIC physiology before all classic late-stage lab abnormalities appear.
| Test | Typical DIC direction | Interpretive caution |
|---|---|---|
| Platelet count | Falls | Can also fall from sepsis, drugs, immune thrombocytopenia, liver disease, or dilution |
| PT/INR | Prolongs | Also prolonged by warfarin, vitamin K deficiency, liver disease, and factor deficiency |
| aPTT | May prolong | Can be affected by heparin, lupus anticoagulant, factor deficiencies, and inhibitors |
| Fibrinogen | Falls in advanced or bleeding-type DIC | May be normal or high in inflammation, sepsis, pregnancy, or early DIC |
| FDP or D-dimer | Rises | Can rise after surgery, trauma, clotting, cancer, pregnancy, infection, and inflammation |
| Blood smear | May show fragmented red cells | Schistocytes suggest microangiopathy but are not specific for DIC |
Blood smear findings can add useful context. Fragmented red blood cells, called schistocytes, may appear when red cells are damaged as they pass through small vessels affected by clots. However, schistocytes are not specific to DIC. They can also occur in thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, severe hypertension, mechanical heart valves, and other microangiopathic processes.
The aPTT result adds another layer. DIC may prolong aPTT, but heparin therapy can do the same. Lupus anticoagulant can prolong aPTT while being linked to clotting risk rather than bleeding risk. Factor deficiencies and acquired inhibitors can also change aPTT. That is why doctors interpret the aPTT result alongside medication history, bleeding signs, and other coagulation tests.
Common Causes and Lookalikes
DIC almost always develops because another serious condition has disturbed the clotting system. It is not usually a stand-alone disease. Finding and treating the trigger is central to care.
Common DIC triggers include:
- Sepsis or severe infection
- Major trauma, crush injury, burns, or shock
- Obstetric emergencies, including placental abruption, amniotic fluid embolism, severe preeclampsia, HELLP syndrome, and postpartum hemorrhage
- Acute promyelocytic leukemia and other severe blood cancers
- Advanced solid tumors, especially mucin-producing adenocarcinomas
- Severe liver injury or acute liver failure
- Major transfusion reactions
- Severe pancreatitis
- Snakebite and certain toxin exposures
- Large vascular abnormalities, aortic aneurysm, or giant hemangioma
DIC lookalikes matter because several disorders can produce low platelets, abnormal clotting tests, high D-dimer or FDP, or bleeding without true DIC.
Severe liver disease can look similar because the liver makes many clotting factors, fibrinogen, natural anticoagulants, and fibrinolytic proteins. PT/INR may be prolonged, platelets may be low from portal hypertension or hypersplenism, and fibrinogen may be low in advanced disease. Comparing albumin and INR with fibrinogen, platelets, liver enzymes, bilirubin, and clinical context can help separate liver synthetic failure from DIC, though both can coexist.
Vitamin K deficiency or warfarin effect can prolong PT/INR but usually does not cause high FDP or low fibrinogen by itself. Heparin can prolong aPTT and thrombin time, and it may complicate DIC interpretation in hospitalized patients.
Thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, and other thrombotic microangiopathies can cause low platelets, organ injury, and schistocytes. In these disorders, PT and aPTT are often normal or less abnormal than expected for DIC, and fibrinogen may be preserved. These conditions need urgent recognition because treatment differs.
Massive bleeding and dilutional coagulopathy can lower fibrinogen and platelets after large fluid or red blood cell transfusion. FDP may rise from injury and clot breakdown, but the pattern is partly driven by blood loss and replacement rather than systemic DIC alone. Trauma patients may have overlapping trauma-induced coagulopathy, DIC physiology, fibrinolysis, hypothermia, acidosis, and dilution.
Recent surgery, pregnancy, cancer, and inflammation can raise FDP or D-dimer without DIC. This is especially common when the patient has no active bleeding, stable platelets, stable PT/aPTT, and no organ dysfunction. A high FDP result in isolation should not be treated as a diagnosis.
Chronic DIC can be subtle. It may occur with advanced cancer or large vascular abnormalities. Fibrinogen may stay normal or even high because the body compensates by making more. FDP or D-dimer may remain elevated, and platelet counts may be mildly low or variable. Chronic DIC may show more clotting problems than bleeding until compensation fails.
What Follow-Up Usually Involves
Follow-up depends on how sick the person is and whether DIC is suspected in an emergency, during hospitalization, or as part of cancer or liver disease care. In unstable patients, follow-up is immediate and repeated. In stable patients, it may involve confirming the abnormality, checking related tests, and looking for the cause.
A typical follow-up plan may include:
- Repeat fibrinogen, FDP or D-dimer, platelet count, PT/INR, and aPTT.
- Compare results with previous values rather than reading each number alone.
- Check for bleeding, bruising, skin changes, shortness of breath, confusion, low urine output, or blood pressure changes.
- Review medications, including warfarin, heparin, direct oral anticoagulants, aspirin, antiplatelet drugs, chemotherapy, and antibiotics.
- Test for the suspected trigger, such as sepsis, trauma complications, obstetric bleeding, malignancy, liver failure, or transfusion reaction.
- Involve hematology, critical care, obstetrics, oncology, surgery, or transfusion medicine when the situation is high risk.
For bleeding or procedure planning, doctors may treat the numbers and the patient together. Fibrinogen replacement may be considered when fibrinogen is very low, especially with active bleeding or high-risk procedures. Replacement may use cryoprecipitate or fibrinogen concentrate, depending on the country, hospital, cause, urgency, and available products. Fresh frozen plasma may be used when multiple clotting factors are depleted and PT/aPTT are prolonged. Platelet transfusion may be considered when platelets are very low or when bleeding risk is high.
For clot-dominant DIC, treatment decisions differ. Some patients have thrombosis, skin ischemia, purpura fulminans, venous thromboembolism, or organ dysfunction from microclots. In selected cases, clinicians may consider anticoagulation, often with heparin, but this requires careful judgment because bleeding risk may also be high. DIC treatment is rarely a simple “thin the blood” or “make the blood clot” decision. The balance depends on the phenotype, bleeding status, clotting status, procedure needs, and underlying disease.
The most important intervention is treating the cause. Antibiotics and source control may be needed for sepsis. Delivery and hemorrhage control may be needed in obstetric DIC. All-trans retinoic acid is urgent in suspected acute promyelocytic leukemia. Surgery, embolization, transfusion support, chemotherapy, or intensive care may be needed depending on the trigger.
A stable trend usually looks like platelets rising or no longer falling, PT/INR shortening, fibrinogen rising or staying adequate, FDP or D-dimer decreasing, bleeding slowing, and organ function improving. A worsening trend looks like falling platelets, falling fibrinogen, rising FDP or D-dimer, longer PT/aPTT, more bleeding, worsening shock, or worsening kidney, liver, lung, or brain function.
Patient Safety and Next Steps
DIC is a medical emergency when it appears with active bleeding, shock, severe infection, trauma, pregnancy complications, cancer crisis, or organ dysfunction. People should not try to interpret fibrinogen and FDP results at home when symptoms are serious. These tests are designed to be interpreted with a full clinical assessment.
Seek urgent care now for any of the following:
- Bleeding that does not stop with pressure
- Vomiting blood, black stools, red blood in stool, or blood in urine
- Sudden heavy vaginal bleeding, especially during pregnancy or after delivery
- New confusion, fainting, seizure, severe weakness, or trouble speaking
- Chest pain, shortness of breath, blue lips, or sudden leg swelling
- Very low blood pressure, clammy skin, or rapid worsening illness
- Purple skin patches, black fingertips or toes, or rapidly spreading bruising
- Fever or suspected sepsis with abnormal clotting tests
For people reviewing outpatient results, the safest next step is to ask the ordering clinician what pattern the full panel shows. Useful questions include:
- Is my fibrinogen low, normal, or high for my situation?
- Is the FDP result mild, moderate, or severe for this lab’s method?
- Are my platelets falling compared with previous tests?
- Are PT/INR or aPTT prolonged?
- Is D-dimer also high?
- Is there a known trigger such as infection, surgery, pregnancy complication, cancer, liver disease, or recent trauma?
- Should these tests be repeated, and how soon?
- Do I need urgent evaluation because of symptoms or the speed of change?
It is also helpful to bring a medication list. Anticoagulants, antiplatelet drugs, hormone therapy, chemotherapy, supplements that affect bleeding, and recent transfusions can all change interpretation. Recent surgery, pregnancy status, cancer history, infection symptoms, liver disease, kidney disease, and any history of clots or bleeding disorders also matter.
Fibrinogen and FDP are powerful clues because they show whether clot material is being built, consumed, and broken down. Their greatest value comes from pattern recognition: low or falling fibrinogen, high or rising FDP, falling platelets, prolonged PT, abnormal aPTT, and a clear clinical trigger. When those pieces line up, clinicians treat the situation as time-sensitive because DIC can change quickly and can affect both bleeding and organ blood flow.
References
- Updated definition and scoring of disseminated intravascular coagulation in 2025: communication from the ISTH SSC Subcommittee on Disseminated Intravascular Coagulation 2025 (Guideline)
- Mortality, diagnosis, and etiology of disseminated intravascular coagulation-a systematic review and meta-analysis: communication from the ISTH SSC subcommittee on disseminated intravascular coagulation 2025 (Systematic Review)
- Phenotypes of Disseminated Intravascular Coagulation 2024 (Review)
- The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation 2023 (Review)
- Sepsis-induced coagulopathy (SIC) in the management of sepsis 2024 (Review)
- Guidelines for the diagnosis and management of disseminated intravascular coagulation 2009 (Guideline)
Disclaimer
Fibrinogen, FDP, D-dimer, PT/INR, aPTT, and platelet results can change quickly in DIC and must be interpreted by a qualified clinician with the patient’s symptoms, medications, and underlying illness. This article is for general education and should not be used to diagnose DIC or decide whether blood products, anticoagulation, or emergency treatment are needed. New bleeding, shock symptoms, pregnancy-related bleeding, severe infection, or rapidly worsening clotting results require urgent medical care.
